5.570USD+6.10%Mkt Cap: 230.58M $P/E: —1d ago
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap230.58M $
Enterprise Value23.53M $
Revenue (TTM)127.48M $
Gross Profit103.01M $
Net Income (TTM)-38.94M $
Revenue/Share3.105 USD
Last Price5.570 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees461
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.95
PEG—
EV/EBITDA-0.45
EV/Revenue0.18
P/S1.81
P/B0.86
EPS (TTM)-1.13
EPS (Forward)-0.56
52W Range
4.48012% of range13.22
52W High13.22 USD
52W Low4.480 USD
Profitability
Gross Margin76.60%
Oper. Margin-57.71%
EBITDA Margin-40.81%
Profit Margin-28.96%
ROE-14.13%
ROA-12.49%
Growth
Revenue Growth-18.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M $
CapEx (TTM)3.83M $
FCF Margin-0.76%
FCF Yield-0.42%
Net Debt-207.05M $
Net Debt/EBITDA3.98
Balance Sheet
Debt/Equity0.04
Current Ratio10.20
Quick Ratio8.78
Book Value/Sh6.459 USD
Cash/Share5.263 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.429 USD
Upside (mean)+51.3%
Target Range6.500 USD – 11.00 USD
$6.500+51.3% to mean$11.00
# Analysts7
Ownership
Shares Out.41.40M
Float39.09M
Insiders6.45%
Institutions93.11%
Short Interest
Short Ratio4.1d
Short % Float14.06%
Short % Out.13.32%
Shares Short5.51M
Short (prev mo.)4.17M
Technical
SMA 505.411 (+2.9%)
SMA 2008.015 (-30.5%)
Beta1.15
S&P 52W Chg20.25%
Avg Vol (30d)1.35M
Avg Vol (10d)1.40M
Technical Indicators
RSI (14)55.8
MACD-0.0233
MACD Signal-0.0749
MACD Hist.+0.0516
BB Upper5.762 USD
BB Middle5.136 USD
BB Lower4.511 USD
BB Width24.35%
ATR (14)0.4269 USD
Vol Ratio (20d)1.63x